Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This is a study to count the number of white blood cells in the cerebrospinal fluid and blood
at the beginning and end of treatment with firategrast and at 4 and 12 weeks after stopping
firategrast. Cerebrospinal fluid flows through and protects the brain and spinal cord. It is
important to understand what happens to the number of white blood cells because they are
important in preventing infections.